Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · IEX Real-Time Price · USD

1.760

-0.020 (-1.12%)

At close: Apr 18, 2024, 4:00 PM

1.762

+0.002 (0.11%)

After-hours: Apr 18, 2024, 7:57 PM EDT

Xeris Biopharma Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	-62.26	-94.66	-122.73	-91.14	-125.58	-60.08	-26.55	-13.21
Depreciation & Amortization	13.16	12.67	1.88	1.47	1.08	0.32	0.23	0.12
Share-Based Compensation	10.72	12.16	11.38	8.27	6.48	1.73	0.5	0.51
Other Operating Activities	-8.64	-33.06	13.93	0.84	13.67	1.75	1.17	-3.5
Operating Cash Flow	-47.02	-102.89	-95.54	-80.56	-104.35	-56.28	-24.66	-16.09
Capital Expenditures	-2.26	-0.52	-1.09	-0.38	-1.11	-1.51	-0.7	-0.04
Acquisitions	0	0	38.47	0	0	0	0	0
Change in Investments	-3.74	34.99	60.58	-27.03	-1.28	-66.75	0	0
Investing Cash Flow	-6	34.46	97.96	-27.41	-2.38	-68.26	-0.7	-0.04
Share Issuance / Repurchase	-0.43	30.37	27.25	62.32	57.91	89.13	0.16	0.02
Debt Issued / Paid	-1.19	97.11	0	63.75	22.62	34.67	0	-0.03
Other Financing Activities	-	-	-	-	-	4.41	34.98	3.91
Financing Cash Flow	-1.61	127.47	27.25	126.06	80.53	128.21	35.14	3.9
Exchange Rate Effect	0	0	-0	-0.02	0	0	0	0
Net Cash Flow	-54.64	59.04	29.67	18.08	-26.2	3.67	9.78	-12.22
Free Cash Flow	-49.29	-103.42	-96.62	-80.94	-105.45	-57.79	-25.36	-16.12
Free Cash Flow Margin	-30.07%	-93.80%	-194.84%	-396.06%	-3874.10%	-2385.02%	-1630.01%	-1499.72%
Free Cash Flow Per Share	-0.36	-0.76	-1.22	-1.90	-4.04	-4.80	-12.51	-8.75

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).